Douglas Blayney
Direttore/Membro del Consiglio presso ARTELO BIOSCIENCES, INC.
Patrimonio netto: 1 118 $ in data 30/04/2024
Profilo
Douglas W.
Blayney is the founder of Asco Quality Symposium.
He currently holds the position of Independent Director at Artelo Biosciences, Inc. since 2017 and is a Professor at Stanford University since 2010.
Previously, he served as the Medical Director & Professor at the University of Michigan Comprehensive Cancer Center from 1999 to 2003, the Medical Director at Stanford Cancer Institute from 2010 to 2015, and the President of the American Society of Clinical Oncology, Inc. from 2009 to 2010.
He completed his undergraduate education at Stanford University and the University of California.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ARTELO BIOSCIENCES INC
0.03% | 22/03/2024 | 834 ( 0.03% ) | 1 118 $ | 30/04/2024 |
Posizioni attive di Douglas Blayney
| Società | Posizione | Inizio |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 31/07/2017 |
| Stanford University | Corporate Officer/Principal | 01/07/2010 |
Precedenti posizioni note di Douglas Blayney
| Società | Posizione | Fine |
|---|---|---|
| Stanford Cancer Institute | Corporate Officer/Principal | 01/07/2015 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Presidente | 01/07/2010 |
| University of Michigan Comprehensive Cancer Center | Direttore Tecnico/Scientifico/R&S | 01/06/2003 |
| Asco Quality Symposium | Fondatore | - |
Formazione di Douglas Blayney
| University of California | Undergraduate Degree |
| Stanford University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARTELO BIOSCIENCES, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
| Stanford Cancer Institute | |
| Asco Quality Symposium |
- Borsa valori
- Insiders
- Douglas Blayney